Around the World's Markets: LONDON
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.EQUITIES WERE hit by worries about hedge funds. The FTSE 100 slid 106.6 points to 5,061, and the mid and small cap indices descended to new lows for year.
Downgradings from analysts also took their toll. Glaxo Wellcome suffered a 90p hit to 1,708p as Goldman Sachs took the shares off its buy list. Centrica, the gas group, was a top performer, climbing 4p to a 121p closing peak on its electricity expansion and prospects for gas exports.
Derek Pain, page 21
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments